These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20470897)

  • 21. Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism.
    Mahley RW
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1305-15. PubMed ID: 27174096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.
    Vuletic S; Peskind ER; Marcovina SM; Quinn JF; Cheung MC; Kennedy H; Kaye JA; Jin LW; Albers JJ
    J Neurosci Res; 2005 May; 80(3):406-13. PubMed ID: 15795933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triacylglycerol-rich lipoproteins alter the secretion, and the cholesterol-effluxing function, of apolipoprotein E-containing lipoprotein particles from human (THP-1) macrophages.
    Lindholm EM; Palmer AM; Graham A
    Biochem J; 2001 Jun; 356(Pt 2):515-23. PubMed ID: 11368780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein E, synaptic plasticity and Alzheimer's disease.
    Poirier J; Minnich A; Davignon J
    Ann Med; 1995 Dec; 27(6):663-70. PubMed ID: 8652146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nascent astrocyte particles differ from lipoproteins in CSF.
    LaDu MJ; Gilligan SM; Lukens JR; Cabana VG; Reardon CA; Van Eldik LJ; Holtzman DM
    J Neurochem; 1998 May; 70(5):2070-81. PubMed ID: 9572293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid lipoproteins in Alzheimer's disease.
    Bassett CN; Montine KS; Neely MD; Swift LL; Montine TJ
    Microsc Res Tech; 2000 Aug; 50(4):282-6. PubMed ID: 10936881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoproteins in the Central Nervous System: From Biology to Pathobiology.
    Raulin AC; Martens YA; Bu G
    Annu Rev Biochem; 2022 Jun; 91():731-759. PubMed ID: 35303786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secretion of lipid-poor nascent human apolipoprotein apoAI, apoCIII, and apoE by cell clones expressing the corresponding genes.
    Hussain MM; Roghani A; Cladaras C; Zanni EE; Zannis VI
    Electrophoresis; 1991 Apr; 12(4):273-83. PubMed ID: 1906400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of lipoprotein metabolism by estrogen in inbred strains of mice occurs primarily by posttranscriptional mechanisms.
    Srivastava RA; Krul ES; Lin RC; Schonfeld G
    Mol Cell Biochem; 1997 Aug; 173(1-2):161-8. PubMed ID: 9278267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, modification, and flotation properties of rat hepatocyte apolipoproteins.
    Hussain MM; Zanni EE; Kelly M; Zannis VI
    Biochim Biophys Acta; 1989 Jan; 1001(1):90-101. PubMed ID: 2912498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E-containing lipoproteins protect neurons from apoptosis via a signaling pathway involving low-density lipoprotein receptor-related protein-1.
    Hayashi H; Campenot RB; Vance DE; Vance JE
    J Neurosci; 2007 Feb; 27(8):1933-41. PubMed ID: 17314289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CSF lipoproteins and Alzheimer's disease.
    Neely MD; Montine TJ
    J Nutr Health Aging; 2002; 6(6):383-91. PubMed ID: 12459889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease.
    Bales KR
    Neuropharmacology; 2010; 59(4-5):295-302. PubMed ID: 20079752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system.
    Bell RD; Sagare AP; Friedman AE; Bedi GS; Holtzman DM; Deane R; Zlokovic BV
    J Cereb Blood Flow Metab; 2007 May; 27(5):909-18. PubMed ID: 17077814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in physiological lipoprotein metabolism.
    Ramasamy I
    Clin Chem Lab Med; 2014 Dec; 52(12):1695-727. PubMed ID: 23940067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secretion of apolipoprotein E by brain glia requires protein prenylation and is suppressed by statins.
    Naidu A; Xu Q; Catalano R; Cordell B
    Brain Res; 2002 Dec; 958(1):100-11. PubMed ID: 12468034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Receptor binding of an apolipoprotein E-rich subfraction of high density lipoprotein to rat and human brain membranes.
    Stewart JE; Skinner ER; Best PV
    Int J Biochem Cell Biol; 1998 Mar; 30(3):407-15. PubMed ID: 9611781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal fluid lipoprotein delivery to human neuronal cells is increased in Alzheimer's disease and is dependent on apoE monomer concentration.
    Bassett CN; Swift LL; Montine KS; Markesbery WR; Montine TJ
    J Alzheimers Dis; 2002 Feb; 4(1):19-30. PubMed ID: 12214015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retinal Muller glia secrete apolipoproteins E and J which are efficiently assembled into lipoprotein particles.
    Shanmugaratnam J; Berg E; Kimerer L; Johnson RJ; Amaratunga A; Schreiber BM; Fine RE
    Brain Res Mol Brain Res; 1997 Oct; 50(1-2):113-20. PubMed ID: 9406925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein changes associated with the plasma lipid-regulating activity of gemfibrozil in cholesterol-fed rats.
    Krause BR; Newton RS
    J Lipid Res; 1985 Aug; 26(8):940-9. PubMed ID: 3862732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.